Sharon A Riddler

6PUBLICATIONS
57CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPharmacogenomicsEnvironmental epidemiologyGene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|May 06, 2025
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1.

Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler

|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Sharon A Riddler, Zoe Moodie, Jesse Clark

|Apr 24, 2024
A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.

Sharon A Riddler, Clifton W Kelly, Craig J Hoesley

|Apr 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.

Binglan Li, Yogasudha Veturi, Anurag Verma

|Feb 15, 2019
Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.

Margaret R Caplan, Raphael J Landovitz, Thesla Palanee-Phillips

Pageof 1

Frequent Collaborators

2 joint publications

Zoe Moodie

2 joint publications

Jesse Clark

2 joint publications

Mary Allen

2 joint publications

Kathryn E Stephenson